Home » Topics » BioWorld Science

BioWorld Science
RSS

Techniclone explores MAb-based drug delivery technologies

Dec. 4, 1996

Assay for diagnosing and monitoring kidney disease available for licensing

Dec. 4, 1996

Method of imaging nicotinic acetylcholine receptors offered for licensing

Dec. 4, 1996

NIH offers invention for treating and diagnosing HIV infection for licensing

Dec. 4, 1996

Another Barr generic drug cleared by the FDA

Dec. 4, 1996

NIH offers licenses for invention related to fusin

Dec. 4, 1996

New therapeutic approach to neurogenerative disorders

Dec. 4, 1996

Neurochem/Parke-Davis collaboration on antiamyloid compounds

Dec. 4, 1996

Forbes Medi-Tech awarded research grant

Dec. 4, 1996

FDA requests additional data on H. pylori diagnostic

Dec. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...